Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-06 Kurtoglu Metin Chief Technology Officer Sale −2,458 $16.83 $41K 62,258
2025-01-03 Kurtoglu Metin Chief Technology Officer Sale −2,417 $16.72 $40K 64,716
2025-01-02 Kurtoglu Metin Chief Technology Officer Grant or award +16,100 67,133
2025-01-02 Kurtoglu Metin Chief Technology Officer Grant or award · Employee Stock Option (right to buy) +47,400 47,400
2024-12-10 Kurtoglu Metin Chief Technology Officer Exercise or conversion +2,901 $1.41 $4K 53,934
2024-12-10 Kurtoglu Metin Chief Technology Officer Sale −2,901 $24.35 $71K 51,033
2024-12-10 Kurtoglu Metin Chief Technology Officer Exercise or conversion · Stock Option (Right to Buy) −2,901 79,099
2024-12-09 Kurtoglu Metin Chief Technology Officer Exercise or conversion +10,763 $1.41 $15K 61,796
2024-12-09 Kurtoglu Metin Chief Technology Officer Sale −6,224 $25.26 $157K 55,572
2024-12-09 Kurtoglu Metin Chief Technology Officer Sale −4,539 $25.83 $117K 51,033
2024-12-09 Kurtoglu Metin Chief Technology Officer Exercise or conversion · Stock Option (Right to Buy) −10,763 82,000
2024-11-21 Kurtoglu Metin Chief Technology Officer Exercise or conversion +32,789 $1.41 $46K 83,822
2024-11-21 Kurtoglu Metin Chief Technology Officer Sale −32,789 $16.67 $547K 51,033
2024-11-21 Kurtoglu Metin Chief Technology Officer Exercise or conversion · Stock Option (Right to Buy) −32,789 92,763
2024-11-20 Kurtoglu Metin Chief Technology Officer Exercise or conversion +5,700 $1.41 $8K 56,733
2024-11-20 Kurtoglu Metin Chief Technology Officer Sale −5,600 $17.28 $97K 51,133
2024-11-20 Kurtoglu Metin Chief Technology Officer Sale −100 $18.09 $2K 51,033
2024-11-20 Kurtoglu Metin Chief Technology Officer Exercise or conversion · Stock Option (Right to Buy) −5,700 125,552
2024-11-19 Kurtoglu Metin Chief Technology Officer Exercise or conversion +200 $1.41 $282 51,233
2024-11-19 Kurtoglu Metin Chief Technology Officer Sale −200 $19.50 $4K 51,033

Page 1 of 3 · 43 trades